First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial
Titel:
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial
Auteur:
Poh, Xuan Ying Lee, I. Russel Tan, Chee Wah Chavatte, Jean-Marc Fong, Siew Wai Goh, Yun Shan Rouers, Angeline Wong, Nathan Torres-Ruesta, Anthony Mah, Shirley Y.Y. Yeoh, Aileen Y.Y. Gandhi, Mihir Rahman, Nabilah Chin, Yi Qing Lim, J. Jonathan Yoong, Terence J.K. Rao, Suma Chia, Po Ying Ong, Sean W.X. Lee, Tau Hong Sadarangani, Sapna P. Lin, Ray J.H. Lim, Daniel R.X. Chia, Wanni Renia, Laurent Ren, Ee Chee Lin, Raymond T.P. Lye, David C. Wang, Lin-Fa Ng, Lisa F.P. Young, Barnaby E.